Dr Reddy’s Q4 results 2026: Pharma major Dr Reddy’s Laboratories on Tuesday, 12 May, reported a sharp 86.2% year-on-year (YoY) fall in its consolidated net profit to ₹220.1 crore for the March quarter of the financial year 2026 (Q4FY26). In the same quarter of the previous financial year, the company’s profit was ₹1,593.9 crore.
Sequentially, or on a quarter-on-quarter (QoQ) basis, Dr Reddy’s profit fell nearly 82% from ₹1,209.8 crore in Q3FY26.
The pharma company’s revenue for the quarter dropped 11.64% YoY and nearly 14% QoQ to ₹7,516.2 crore. In Q4FY25, Dr Reddy’s revenue was ₹8,506 crore, while in Q3FY26, it was ₹8,726.80 crore.
(This is a developing story. Please check back for fresh updates.)